Breast biopsies after neoadjuvant chemotherapy accurately predict presence of residual breast cancer

Breast biopsies after neoadjuvant chemotherapy accurately predict presence of residual breast cancer

Henry Kuerer, M.D., Ph.D.

Protocol identifies breast cancer patients for study in which surgery may be eliminated Abstract: GS5-04 SAN ANTONIO ― Researchers from The University of Texas MD Anderson Cancer Center have identified a standardized protocol that uses image-guided breast biopsies to reliably predict residual disease in breast cancer patients and that potentially identifies exceptional responders who may not require surgery. Utilizing this technique, a multicenter clinical trial led by Henry Kuerer, M.D., Ph.D., professor of Breast Surgical Oncology, is studying the elimination of surgery […]